Experienced in Peripheral Neuropathy

Chin-chang T. Huang

No. 199, Tun Hwa North Road, 10547Taiwan, 
TN 
Experienced in Peripheral Neuropathy
No. 199, Tun Hwa North Road, 10547Taiwan, 
TN 
OverviewLocationsClinical Research

Overview

Chin-chang Huang practices in Tunisia. Huang is rated as an Experienced expert by MediFind in the treatment of Peripheral Neuropathy. Their top areas of expertise are Tolosa Hunt Syndrome, Acute Intermittent Porphyria, Dementia, and Alzheimer's Disease.

Their clinical research consists of co-authoring 80 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Peripheral Neuropathy.

Locations

No. 199, Tun Hwa North Road, 10547Taiwan, Tunisia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

An Extension Study of a Phase IIa Study in Patients With Mild Alzheimer's Disease to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UBITh® AD Immunotherapeutic Vaccine (UB-311)
An Extension Study of a Phase IIa Study in Patients With Mild Alzheimer's Disease to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UBITh® AD Immunotherapeutic Vaccine (UB-311)
Enrollment Status: Terminated
Publish Date: January 26, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, 3-arm Parallel-group, Multicenter, Phase IIa Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UBITh® AD Immunotherapeutic Vaccine (UB-311) in Patients With Mild Alzheimer's Disease
A Randomized, Double-blind, Placebo-controlled, 3-arm Parallel-group, Multicenter, Phase IIa Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UBITh® AD Immunotherapeutic Vaccine (UB-311) in Patients With Mild Alzheimer's Disease
Enrollment Status: Completed
Publish Date: March 17, 2020
Intervention Type: Drug, Biological
Study Phase: Phase 2
Imaging the Neural Network Connectivity on Patients With Mild Cognitive Impairment
Imaging the Neural Network Connectivity on Patients With Mild Cognitive Impairment
Enrollment Status: Completed
Publish Date: July 18, 2018
View 2 Less Clinical Trials

80 Total Publications

Visual interpretation of [18F]Florzolotau Tau-PET imaging for differentiating alzheimer's disease and progressive supranuclear palsy.
Visual interpretation of [18F]Florzolotau Tau-PET imaging for differentiating alzheimer's disease and progressive supranuclear palsy.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Huang's expertise for a condition
ConditionClose
    View All 25 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile